How is the Renal Biomarkers Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the renal biomarkers market grown over the years?
The market size for renal biomarkers has experienced significant growth in the past few years. Projections indicate an increase from $1.28 billion in 2024 to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.8%. This growth during the historical period is the result of various factors, including a higher incidence of kidney diseases, advancements in medical diagnostic tools, an aging population, the increased recognition of the importance of early disease detection, the adoption of point-of-care testing, and a rise in chronic diseases.
What Is the forecasted market size and growth rate for the renal biomarkers market?
Anticipations are for a robust expansion of the renal biomarkers market in the coming years, with projections putting it at $1.91 billion by 2029 and a Compound Annual Growth Rate (CAGR) of 8.5%. This predicted growth in the given forecast period can be ascribed to developments in precision medicine and targeted therapies, implementation of biomarker tests in regular clinical practices, blossoming markets in Asia and Latin America, non-invasive methods of testing biomarkers, and perpetual monitoring via wearable devices. Key trends expected during this period are multifaceted biomarker panels for thorough disease profiling, the application of artificial intelligence and machine learning in biomarker identification, companion diagnostics based on biomarkers, point-of-care biomarker testing in homes, and biomarkers used for early detection and prevention.
Get your renal biomarkers market report here!
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report
What are the major factors driving growth in the renal biomarkers market?
The renal biomarkers market is projected to expand due to an increase in geriatric and pediatric renal patients. Elderly patients over 70 years old with advanced chronic kidney disease (CKD) are referred to as geriatric renal patients. Pediatric renal patients, on the other hand, are those diagnosed with a renal disorder during childhood or early adulthood. Renal biomarkers are used to determine the severity of renal injury in these geriatric and pediatric renal patients. For example, the Australian Institute of Health and Welfare, a government agency based in Australia, reported in June 2024 that chronic kidney disease (CKD) mortality rates rose by 4.2% in 2021 and 6.2% in 2022. Hence, the increase in geriatric and pediatric renal patients is fuelling the growth of the renal biomarkers market.
What key areas define the segmentation of the global renal biomarkers Market?
The renal biomarkers market covered in this report is segmented –
1) By Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types
2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)
3) By Application: Diagnosis And Disease Progression Monitoring, Research Homecare
4) By End User: Hospitals, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Functional Biomarker: Creatinine, Urea, Cystatin C, Bicarbonate
2) By Up Regulated Protein: Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), Interleukin-18 (IL-18)
3) By Other Biomarker Types: Proximal Tubule Injury Biomarkers, Acute Kidney Injury Biomarkers, Chronic Kidney Disease Biomarkers
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7711&type=smp
What are the top market players propelling the growth of the renal biomarkers industry?
Major companies operating in the renal biomarkers market include Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter Inc., Astute Medical Inc., Nexelis Company, Sphingotec GmbH, Bio-Rad Laboratories India Pvt. Ltd., Enzo Biochem Inc., PerkinElmer Inc., Novartis AG, Alere Inc., AstraZeneca plc, Bio-Techne Corp., DiaSorin S.p.A., EKF Diagnostics Holdings plc, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Merck KGaA, Myriad RBM Inc., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, R&D Systems Inc., Roche Diagnostics International Ltd ., Sekisui Chemical Co. Ltd., Sysmex Corporation, Tosoh Bioscience Inc.
What are the key trends shaping the future of the renal biomarkers market?
Innovations in technology have been identified as a key emerging trend in the renal biomarkers market. The major industry players in the renal biomarkers area are concentrating on creating inventive solutions to maintain their market dominance. For example, Nipro Medical Corporation, a medical equipment manufacturer based in the United States, unveiled the SURDIAL DX in March 2022. This novel hemodialysis system, SURDIAL DX, offers state-of-the-art technology to ensure maximum safety, comfort, and efficiency for patients. It consists of modern design components such as improved automated procedures, ergonomic design, and a commitment to augmenting the dialysis treatment experience as a whole.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7711
What regions are dominating the renal biomarkers market growth?
North America was the largest region in the renal biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered in the renal biomarkers market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Psoriasis Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report
Scientific Research And Development Services Global Market Report 2024
Site Remediation Consulting Services Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
